dr. liu on phase 2 study results of adavosertib in recurrent uterine serous carcinoma
Published 4 years ago • 327 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:38
dr. liu on cediranib/olaparib in recurrent ovarian cancer
-
1:24
dr. santin on impact of trastuzumab in uterine serous carcinoma
-
1:27
dr. fader on trastuzumab/chemo in her2 uterine serous carcinoma
-
2:07
dr. fader on adding trastuzumab to chemo in her2 uterine serous carcinoma
-
1:45
dr. yadav on the olaparib/neratinib combo in her2 uterine serous carcinoma
-
45:32
extra-uterine high-grade serous carcinoma: closing the loop?
-
2:03
efficacy results for trastuzumab in her2-positive uterine serous carcinoma
-
1:24
dr. yadav on synergy of novel combination in uterine serous carcinoma
-
1:06
dr. santin on rationale for trastuzumab in uterine serous carcinoma
-
2:03
dr. yadav on olaparib/neratinib in her2-overexpressing uterine serous carcinoma
-
4:40
part 5 - uterine papillary serous carcinoma (upsc) - my personal journey
-
2:55
esgo eacademy editors recommend ijgc article: adjuvant treatment in uterine serous carcinoma
-
1:22
dr. oaknin discusses findings of the garnet study in endometrial cancer
-
6:31
part 6 - uterine papillary serous carcinoma (upsc) - a rare form of endometrial cancer
-
1:02
dr. yadav on differences in type 1 and type 2 uterine cancer
-
1:22
dr. kauff on challenges in treating uterine cancer
-
2:41
new research could change how endometrial cancer is treated
-
1:27
dr. wingo on the evolution of surgery in endometrial cancer
-
1:01:40
not all uterine cancer is the same: what to know about rare uterine cancers